BioNTech IMFS is a subsidiary of BioNTech SE with a focus on developing and manufacturing innovative products including viral vectors, cells, and ivt mRNA. The company boasts extensive expertise in scientific, technical, and regulatory requirements and operates state-of-the-art GMP facilities, ensuring safe and cost-efficient product development and manufacturing. BioNTech IMFS offers contract services for retroviral vector manufacturing for clinical supply. With over 500 experienced employees, the company is constantly seeking motivated individuals to join its team. Founded in 1997, BioNTech IMFS operates in the biotechnology, health and wellness, and manufacturing industries. For more information, visit www.biontech-imfs.de.
There is no investment information
No recent news or press coverage available for BioNTech IMFS.
We care about your data, and we'd love to use cookies make your experience better.
